MedPath

Comparison of two different drugs as adjuvants to local anesthesia in supraclavicular brachialplexus block for upper limb surgeries

Not yet recruiting
Registration Number
CTRI/2021/05/033452
Lead Sponsor
Dr Anitha A
Brief Summary

| |

| --- |

|

To compare the effect of Nalbuphine and Fentanyl as an adjuvant to Ropivacaine in

ultrasound guided interscalene brachial plexus block with respect to



1. To assess the onset and duration of sensory and motor blockade.



2. To assess duration of analgesia.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
60
Inclusion Criteria

American Society of Anesthesiologist physical status 1 and 2.

Exclusion Criteria
  • Any neurological deficit, peripheral neuropathies, myopathies or chronic pain in the operative limb.
  • History of anaphylaxis to local anaesthetics or known allergy to any of the study drugs to be used.
  • Any history of bleeding diathesis or coagulation abnormalities.
  • Any skin infection or local disease at the needle insertion site.
  • BMI more than 35kg/sq-m, failure to achieve adequate block within 30 mins of administration.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Time to onset of sensory and motor block.Time to onset of sensory and motor block. | Duration of sensory and motor block. | Duration of analgesia
Duration of sensory and motor block.Time to onset of sensory and motor block. | Duration of sensory and motor block. | Duration of analgesia
Duration of analgesiaTime to onset of sensory and motor block. | Duration of sensory and motor block. | Duration of analgesia
Secondary Outcome Measures
NameTimeMethod
Pain scoresAdverse effects- Hypotension, Bradycardia,

Trial Locations

Locations (1)

Kempagowda Institute of medical science

🇮🇳

Bangalore, KARNATAKA, India

Kempagowda Institute of medical science
🇮🇳Bangalore, KARNATAKA, India
Dr Anitha A
Principal investigator
9842444924
anithaads91@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.